Rocket One Inc.

Rocket One Inc. (HOTH) priced its initial public offering on Feb 15, 2019 at $5.60 per share, within its $5.50–$6.50 range, raising $7M, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $52.8M. Laidlaw was lead-left underwriter. Sheppard Mullin advised the company and Lowenstein Sandler advised the underwriters.

Rocket One Inc. is a development-stage biopharmaceutical company incorporated in May 2017, focused on targeted therapeutics for conditions such as atopic dermatitis. It holds a sublicense to the BioLexa Platform, developed at the University of Cincinnati, and plans to start with a topical cream for eczema.

Status

IPO

Ticker

HOTH

Exchange

Nasdaq Capital Market

Priced

Feb 15, 2019

IPO price

$5.60

Price range

$5.50–$6.50

Raised

$7M

Market cap at IPO price

$52.8M

First filed

Oct 10, 2018

Underwriters

Laidlaw

Company counsel

Sheppard Mullin

Underwriters' counsel

Lowenstein Sandler

Sector

Biotech & pharma

Country / state

NJ

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.